✦ LIBER ✦

667 Relation of Bax and Bcl2 with apoptosis and grade in neuroendocrine (NE) lung tumors other than small cell lung carcinoma

✍ Scribed by Brambilla, E.; Negoescu, A.; Moro, D.; Lantuéjoul, S.; Brambilla, C.; Hasleton, P.

Book ID: 123439516
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 129 KB
Volume: 18
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)80047-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of smoking with apoptosis-re

Association of smoking with apoptosis-regulated proteins (Bcl-2, Bax and p53) in resected non-small-cell lung cancers

✍ Takaomi Hanaoka; Jun Nakayama; Jun Mukai; Shinji Irie; Takeshi Yamanda; Taka-Aki 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 42 KB 👁 2 views

FIGURE 1 -Survival after surgery of patients with NSCLC according to p53 expression level. Log-rank tests used for comparisons.

CD40 and Bcl2 expression in squamous cel

CD40 and Bcl2 expression in squamous cell carcinoma of the lung: correlation with apoptosis, survival, and other clinicopathological factors

✍ Ghosh, Monimoy; Crocker, John; Morris, Alan G. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 3 views

CD40 is a cell surface receptor which, when ligated, modulates apoptosis in some cell types, perhaps via activation of the expression of members of the Bcl2 gene family. This study sought to determine whether expression of CD40 in a series of 134 squamous cell carcinomas (SCCs) of the lung was relat

P-674 Cyclooxygenase-2 expression in non

P-674 Cyclooxygenase-2 expression in non-small cell lung cancer: Relation to expressions of p53, Bcl-2, Bax, tumor cell proliferation, and survival

✍ Sis, B.; Kargi, A.; Ulukus, C.; Oztop, I.; Akkoclu, A.; Sanli, A.; Onen, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Accelerated apoptosis and low Bcl-2 expr

Accelerated apoptosis and low Bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung

✍ Anna-Kaisa Eerola; Henni Ruokolainen; Ylermi Soini; Hannu Raunio; Paavo PÄÄKKÖ 📂 Article 📅 1999 🏛 Springer Netherlands 🌐 English ⚖ 149 KB

Phase I Study of Navitoclax (ABT-263), a

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

✍ Gandhi, L.; Camidge, D. R.; Ribeiro de Oliveira, M.; Bonomi, P.; Gandara, D.; Kh 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 299 KB

Phase I Study of Navitoclax (ABT-263), a

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

✍ Gandhi, L.; Camidge, D. R.; Ribeiro de Oliveira, M.; Bonomi, P.; Gandara, D.; Kh 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 299 KB

## Purpose Resistance to chemotherapy-induced apoptosis represents a major obstacle to cancer control. Overexpression of Bcl-2 is seen in multiple tumor types and targeting Bcl-2 may provide therapeutic benefit. A phase I study of navitoclax, a novel inhibitor of Bcl-2 family proteins, was conduct